CHC LABS INC.
|
MAGNESIUM (83735) |
|
|
242.00-242.91 |
Thyrotoxicosis, with or without goiter |
|
250.10-250.13 |
Diabetes with ketoacidosis |
|
250.20-250.23 |
Diabetes with hyperosmolarity |
|
250.30-250.33 |
Diabetes with other coma |
|
250.40-250.43 |
Diabetes with renal manifestations |
|
250.50-250.53 |
Diabetes with ophthalmic manifestations |
|
250.60-250.63 |
Diabetes with neurological manifestations |
|
250.70-250.73 |
Diabetes with peripheral circulatory disorders |
|
250.80-250.83 |
Diabetes with other specified manifestations |
|
252.0 |
Hyperparathyroidism |
|
252.1 |
Hypoparathyroidism |
|
252.8 |
Other specified disorders of parathyroid gland |
|
253.6 |
Other disorders of neurohypophysis (Syndrome of inappropriate antiduretic hormone, [ADH] |
|
255.1 |
Hyperaldosteronism |
|
255.4 |
Corticoadrenal insufficiency |
|
259.3 |
Ectopic hormone secretion, not elsewhere classified |
|
260 |
Kwashiorkor |
|
261 |
Nutritional marasmus |
|
262 |
Other severe, protein-calorie malnutrition |
|
263.0 |
Malnutrition of moderate degree |
|
263.8 |
Other protein-calorie malnutrition |
|
275.2 |
Disorders of magnesium metabolism |
|
275.40-275.49 |
Disorders of calcium metabolism |
|
276.2 |
Acidosis |
|
276.4 |
Mixed acid-base balance disorder |
|
276.5 |
Volume depletion |
|
276.7 |
Hyperpotassemia |
|
276.8 |
Hypopotassemia |
|
293.0-293.1 |
Acute and subacute delirium |
|
303.90-303.93 |
Other and unspecified alcohol dependence |
|
305.00-305.03 |
Alcohol abuse |
|
307.1 |
Anorexia nervosa |
|
307.51 |
Bulimia |
|
307.52 |
Pica |
|
333.2 |
Myoclonus |
|
333.3 |
Tics of organic origin |
|
410.00-410.92 |
Acute myocardial infarction |
|
424.0 |
Mitral valve disorders (MVP) |
|
427.0-427.89 |
Cardiac dysrhythmias |
|
428.0 |
Congestive heart failure, unspecified |
|
458.0-458.8 |
Hypotension |
|
536.2 |
Persistent vomiting |
|
577.0-577.9 |
Diseases of pancreas |
|
579.3 |
Other and unspecified postsurgical malabsorption |
|
579.8 |
Other specified intestinal malabsorption |
|
584.5-584.9 |
Acute renal failure |
|
585 |
Chronic renal failure |
|
588.8 |
Other specified disorders resulting from impaired renal function |
|
593.81 |
Vascular disorders of kidney |
|
643.10-643.83 |
Excessive vomiting in pregnancy |
|
646.80-646.84 |
Other specified complications of pregnancy |
|
728.89 |
Other disorders of muscle, ligament, and fascia (rhabdomyolysis) |
|
763.81-763.89 |
Other specified complications of labor and delivery affecting fetus or newborn |
|
780.01 |
Coma |
|
780.02 |
Transient alteration of awareness |
|
780.09 |
Other alteration of consciousness |
|
780.2 |
Syncope and collapse |
|
780.31-780.39 |
Convulsions |
|
781.0 |
Abnormal involuntary movements |
|
781.7 |
Tetany |
|
783.0 |
Anorexia |
|
785.0 |
Tachycardia, unspecified |
|
785.50-785.59 |
Shock without mention of trauma |
|
787.01-787.03 |
Nausea and vomiting |
|
787.91 |
Diarrhea |
|
790.6 |
Other abnormal blood chemistry |
|
794.31 |
Abnormal electrocardiogram [ECG] [EKG] |
|
794.4 |
Nonspecific abnormal results of function studies, kidney |
|
796.1 |
Abnormal reflex |
|
799.4 |
Cachexia |
|
941.00-949.5 |
Burns |
|
958.4 |
Traumatic shock |
|
995.2 |
Unspecified adverse effect of drug, medicinal and biological substance (amphotericin B and digitalis) |
|
997.1 |
Cardiac complications |
|
998.0 |
Postoperative shock |
|
V42.0 |
Organ or tissue replaced by transplant, kidney |
|
V42.7 |
Organ or tissue replaced by transplant, liver |
|
V56.0 |
Extracorporeal dialysis |
|
V56.8 |
Other dialysis |
|
V58.1 |
Encounter for other and unspecified procedures and aftercare, chemotherapy (Cis-platinum) |
|
V58.69 |
Long term (current) use of other medications (high risk) |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|